Assessment of antigenicity and genetic variation of glycoprotein B of mnrine cytomgealovirus murine cytomegalovirus

Journal of General Virology

Volumn 77, Issue 1, 1996, Pages 49-59

  Xu, Jiake ^a,b   Lyons, Paul A ^a,c   Carter, Meredith D ^a,d   Booth, Timothy W M ^a   Davis Poynter, Nicholas J ^a   Shellam, Geoffrey R ^a   Scalzo, Anthony A ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; VIRUS GLYCOPROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ANTIGENICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CYTOMEGALOVIRUS; ESCHERICHIA COLI; GENETIC VARIABILITY; IMMUNIZATION; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BASE SEQUENCE; BINDING SITES; BINDING SITES, ANTIBODY; CELL LINE; DNA PRIMERS; ESCHERICHIA COLI; FEMALE; HERPESVIRIDAE INFECTIONS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUROMEGALOVIRUS; NEUTRALIZATION TESTS; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; VACCINATION; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS;

EID: 0030070129     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-1-49     Document Type: Article

References (48)

1. ALLAN, J. E. & SHELLAM. G. R. (1984). Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice. Archives of Virology 81, 139-150.
2. AYATA, M., SUGANO, T., MURAYAMA, T., SAKAMURO, D., TAKEGAMI, T., MATSUMOTO, Y. & FURUKAWA, T. (1994) Different antibody response to a neutralizing epitope of human cytomegalovirus glycoprotein B among seropositive individuals. Journal of Medical Virology 43, 386-392.
3. BASGOZ, N., QADRI, I., NAVARRO, D., SEARS, A., LENNETTE, E., YOUNGBLOM, J. & PEREIRA, L. (1992). The amino terminus of human cytomegalovirus glycoprotein B contains epitopes that vary among strains. Journal of General Virology 73, 983-988.
4. BLACKLAWS, B. A., KRISHNA, S , MINSON, A. C. & NASH, A. A. (1990) Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology 177, 727-736.
5. BOOTH, T. W. M., SCALZO, A. A , CARRELLO, C., LYONS, P. A., FARRELL, H.H., SINGLETON, G. R. & SHELLAM, G. R. (1993). Molecular and biological characterization of new strains of murine cytomegalovirus isolated from wild mice. Archives of Virology 132, 209-220.
6. BORYSIEWICZ, L. K., HICKLING, J. K., GRAHAM, S., SINCLAIR, J., CRANAGE, M. P., SMITH, G. L. & SISSONS, J. G. P. (1988). Human cytomegalovirus specific cytotoxic T cells: relative frequency of stage-specific CTL recognizing the 72-kDa immediate-early protein and glycoprotein B expressed by recombinant vaccinia viruses. Journal of Experimental Medicine 168, 919-931.
7. BRITT, W. J., VUGLER, L., BUTFILOSKI, E. J. & STEPHENS, E. B. (1990). Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. Journal of Virology 64, 1079-1085.
8. CHOU, S. & DENNISON, K. M. (1991) Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes Journal of Infectious Diseases 163, 1229-1234.
9. CRANAGE, M. P., KOUZARIDES, T., BANKIER, A. T., SATCHWELL, S., WESTON, K., TOMLINSON, P., BARRELL, B., HART, H., BELL, S. E., MINSON, A C. & SMITH, G. L. (1986). Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccrnia virus. EMBO Journal 5, 3057-3063.
10. DARLINGTON, J., SUPER, M., PATEL, K., GRUNDY, J. E., GRIFFITHS, P. D. & EMERY, V. C. (1991). Use of the polymerase chain reaction to analyse sequence variation within a major neutralizing epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus. Journal of General Virology 72, 1985-1989.
11. FARRELL, H E. & SHELLAM, G. R. (1989). Immunoblot analysis of the antibody response to murine cytomegalovirus in genetically resistant and susceptible mice. Journal of General Virology 70, 2573-2586.
12. FARRELL, H. E. & SHELLAM, G. R. (1990). Characterization of neutralizing monoclonal antibodies to murine cytomegalovirus Journal of General Virology 71, 655-664.
13. FARRELL, H. E. & SHELLAM, G. R. (1991). Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies. Journal of General Virology 72, 149-156.
14. GHIASI, H., KAIWAR, R., NESBURN, A. B., SLANINA, S. & WECHSLER, S. L. (1994). Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and g1): comparative protection against lethal challenge in mice. Journal of Virology 68, 2118-2126.
15. GÖNCZÖL, E , DETAISNE, C., HIRKA, G., BERENCSI, K., LIN, W., PAOLETTI, E. & PLOTKIN, S. (1991). High expression of human cytomegalovirus (HCMV)-gB protein in cells infected with a vaccinia-gB recombinant: the importance of the gB protein in HCMV immunity. Vaccine 9, 631-637.
16. GRETCH, D. R , KARI, B., RASMUSSEN, L., GEHRZ, R. C. & STINSKI, M. F. (1988). Identification and characterization of three distinct families of glycoprotein complexes in the envelopes of human cytomegalovirus. Journal of Virology 62, 875-881.
17. HUDSON, J. B. (1979). The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections. Archives of Virology 62, 1-29.
18. KIM, K. S , SAPIENZA, V. J., CARP, R. I, & MOON, H. M. (1976). Analysis of structural proteins of purified murine cytomegalovirus. Journal of Virology 17, 906-915.
19. KNIESS, N., MACH. M , FAY, J. & BRITT, W. J. (1991). Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus. Journal of Virology 65, 138-146.
20. KYTE, J. & DOOLITTLE, R. F. (1982). A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology 157, 105-132.
21. LAEMMLI, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
22. LEHNER, R., STAMMINGER, T. & MACH, M. (1991). Comparative sequence analysis of human cytomegalovirus strains. Journal of Clinical Microbiology 29, 2494-2502.
23. LI, W., EIDMAN, K., GERHZ, R. C. & KARI, B. (1995). Identification and molecular characterization of the murine cytomegalovirus homolog of the human cytomegalovirus UL100 gene. Virus Research 36, 163-175.
24. LIU, Y.-N. C., KLAUS, A., KARI, B., STINSKI, M. F., ECKHARDT, J. & GEHRZ, R C. (1991). The N-terminal 513 amino acids of the envelope glycoprotein gB of human cytomegalovirus stimulates both B- and T-cell immune responses in humans. Journal of Virology 65, 1644-1648.
25. LOH, L. C (1991). Synthesis and processing of the major envelope glycoprotein of murine cytomegalovirus. Virology 180, 239-250.
26. LOH, L. C., BALACHANDRAN, N. & QUALTIERE, L. F. (1988). Characterization of a major virion envelope glycoprotein complex of murine cytomegalovirus and its immunological cross-reactivity with human cytomegalovirus. Virology 166, 206-216.
27. MEYER, H., MASUHO, Y. & MACH, M. (1990). The gp116 of the gp58/116 complex of human cytomegalovirus represents the aminotermmal part of the precursor molecule and contains a neutralizing epitope Journal of General Virology 71, 2443-2450.
28. MEYER, H , SUNDQVIST, V.-A., PEREIRA, L. & MACH, M. (1992). Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies. Journal of General Virology 73, 2375-2383.
29. MOCARSKI, E., POST, L E. & ROIZMAN, B (1980). Molecular engineering of the herpes simplex virus genome: insertion of a second L-S junction into the genome causes additional genome inversions. Cell 22, 243-255.
30. QADRI, I., NAVARRO, D., PAZ, P. & PEREIRA, L. (1992). Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus. Journal of General Virology 73, 2913-2921.
31. RAPP, M., LUCIN, P , MESSERLE, M., LOH, L. C. & KOSZINOWSKI, U. H. (1994). Expression of the murine cytomegalovirus glycoprotein H by recombinant vaccinia virus. Journal of General Virology 75, 183-188.
32. RAPP, M., MESSERLE, M., BÜHLER, B., TANNHEIMER, M., KEIL, G. M. & KOSZINOWSKI, U. H. (1992). Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus. Journal of Virology 66, 4399-4406.
33. RASMUSSEN, L. (1990). Immune response to human cytomegalovirus infection. Current Topics in Microbiology and Immunology 154, 221-254.
34. RASMUSSEN, L. (1993). Progress in the development of a human cytomegalovirus glycoprotein subunit vaccine. In Multidisciplinary Approach to Understanding Cytomegalovirus Disease: Excerpta Medica, pp. 311-320. Edited by S. Michelson & S. A. Plotkin. Amsterdam: Elsevier.
35. RIDDELL, S R.. REUSSER, P. & GREENBERG, P. D. (1991). Cytotoxic T cells specific for cytomegalovirus: a potential therapy for immuno-compromised patients. Reviews in Infectious Diseases 13 (Suppl. 11), 966-973
36. ROY, D. M., GRUNDY, J. E. & EMERY, V. C. (1993). Sequence variation within neutralizing epitopes of the envelope glycoprotein B of human cytomegalovirus: comparison of isolates from renal transplant recipients and AIDS patients. Journal of General Virology 74, 2499-2505.
37. SCALZO, A A., ELLIOTT, S. L., COX, J., GARDNER, J., MOSS, D. J. & SUHRBIER, A. (1995 a). Induction of protective cytotoxic T cells to murine cytomegalovirus using a nonapeptide and a human compatible adjuvant (Montanide ISA 720). Journal of Virology 69, 1306-1309.
38. SCALZO, A A., FORBES, C. A., DAVIS-POYNTER, N. J., FARRELL, H. E. & LYONS, P. A. (1995 b). DNA sequence and transcriptional analysis of the glycoprotein M gene of murine cytomegalovirus. Journal of General Virology 76, 2895-2901.
39. SHIU, S Y. W., CHAN, K. M., LO, S. K. F., IP, K W. Y., YUEN, K. Y. & HEATH, R. B. (1994), Sequence variation of the amino-terminal antigenic domains of glycoprotein B of human cytomegalovirus strains isolated from Chinese patients. Archives of Virology 137, 133-138.
40. SMITH, D. B. & JOHNSON, K. S (1988). Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67, 31-40.
41. SPAETE, R. R., SAXENA, A., SCOTT, P. I., SONG, G. J., PROBERT, W. S., BRITT, W. J., GIBSON, W., RASMUSSEN, L. & PACHL, C. (1990). Sequence requirements for proteolytic processing of glycoprotein B of human cytomegalovirus strain Towne. Journal of Virology 64, 2922-2931.
42. SPEAR, P. G. (1985). Glycoproteins specified by herpes simplex virus. In The Herpesviruses, pp. 315-356. Edited by B. Roizman & C. Lopez. New York: Plenum Press.
43. SPEAR, P. G. (1993). Entry of alphaherpesviruses into cells. Seminars in Virology 4, 167-180.
44. TOWBIN, H., STAEHELIN, T. & GORDON, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, USA 76, 4350-4354.
45. UTZ, U., BRITT, W., VUGLER, L. & MACH, M. (1989). Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. Journal of Virology 63, 1995-2001.
46. XU, J., DALLAS, P. B., LYONS, P. A., SHELLAM, G R. & SCALZO, A. A. (1992). Identification of the glycoprotein H gene of murine cytomegalovirus. Journal of General Virology 73, 1849-1854.
47. XU, J., SCALZO, A. A., LYONS, P. A. & SHELLAM, G. R. (1994 a). Expression of the glycoprotein H of murine cytomegalovirus and identification of an N-terminal antibody-binding region. Virology 204, 466-470.
48. XU, J., SCALZO, A. A., LYONS, P. A., FARRELL, H. E., RAWLINSON, W. D. & SHELLAM, G. R. (1994 b). Identification, sequencing and expression of the glycoprotein L gene of murine cytomegalovirus Journal of General Virology 75, 3235-3240.